European Psychiatry

Mental illness in representative samples of homeless males in the city of Munich, Germany
pp. 153s-153s(1)
Authors: Fichter M.M.; Quadflieg N.; Gnutzmann A.

The future of the mental hospital
pp. 153s-153s(1)
Author: Leff J.

Who is in need of long-term community care?
pp. 153s-154s(2)
Author: Rossler W.

Abstract(s)
pp. 154s-154s(1)
Author: Sartorius N.

Conclusions: symposium ''psychiatric and public health''
pp. 154s-154s(1)
Author: Singer L.

Suicide and addictions
pp. 154s-154s(1)
Author: Berglund M.

Substance use disorders: epidemiological overview of psychiatric comorbidity
pp. 154s-155s(2)
Authors: Helgason T.; Tomasson K.

Anxiety disorders and addictions
pp. 155s-155s(1)
Author: Poldrugo F.

HPA regulation in depression
pp. 155s-155s(1)
Authors: Checkley S.A.; Sayal K.; Papadopoulos A.; Gibson L.; Reynolds M.

The role of adrenal steroids in brain function and dysfunction with particular reference to cortisol and DHEA
pp. 155s-155s(1)
Author: Herbert J.

The hypothalamus of depressed patients
pp. 156s-156s(1)
Authors: Hoogendijk W.J.G.; Purba J.S.; Raadsheer F.C.; Zhou J.N.; Hofman M.A.; Swaab D.F.

The disruption of corticosteroid feedback in chronic stress
pp. 156s-156s(1)
Author: Lightman S.L.

Altered hypothalamic-pituitary-adrenocortical regulation in individuals at high familial risk for affective disorders
pp. 156s-156s(1)
Authors: Modell S.; Holsboer F.

Validity studies
pp. 156s-157s(2)
Author: Brockington I.F.

ICD-10, experiences in western europe
pp. 157s-157s(1)
Author: Lopez-Ibor J.J.

Introduction to the ICD-10 course
pp. 157s-157s(1)
Author: Sartorius N.

Experiences in central and eastern europe
pp. 157s-157s(1)
Authors: Smolik P.; Zvolsky P.

The outcome of home-treatment compared to inpatient treatment of children with psychiatric disorders
pp. 157s-157s(1)
Authors: Blanz B.; Schmidt M.H.

Early onset bulimia nervosa: life events, depressive features and two-year follow-up
pp. 157s-158s(2)
Authors: Flament M.F.; Delvenne V.; Franck N.; Jeammet P.

New developments in the study of affective disorders in young people
pp. 158s-158s(1)
Author: Goodyer I.

Controlled trial of a brief cognitive-behavioural intervention in adolescents parents with depressive disorders
pp. 158s-158s(1)
Author: Harrington R.C.

Negative and depressive symptoms in acute schizophrenic episodes- do they improve under neuroleptic treatment?
pp. 158s-159s(2)
Authors: Benkert O.; Muller-Siecheneder F.; Wetzel H.

Brain change over time in schizophrenia -- relationship to negative symptoms and outcome
pp. 159s-159s(1)
Authors: DeLisi L.E.; Sakuma M.; Polina D.; Grimson R.

Brain imaging of dopaminergic variables in negative schizophrenia, and during neuroleptic treatment
pp. 159s-159s(1)
Authors: Martinot J.L.; Paillere-Martinot M.L.; Dao-Castellana M.H.; Levy D.; Poirier M.F.; Lecrubier Y.; Allilaire J.F.; Manus A.; Feline A.

Psychopharmacology of positive and negative symptoms of schizophrenia: behavioural models and pharmacological profiles
pp. 159s-160s(2)
Authors: Sanger D.J.; Depoortere R.; Perrault G.; Scatton B.

Neural networks, neuroplasticity, and neuromodulation: a framework for understanding formal thought disorder and delusions
pp. 160s-160s(1)
Author: Spitzer M.

Addictions and depressive disorders
pp. 160s-160s(1)
Authors: Ades J.; Lejoyeux M.

Results of a controlled multicenter study with ritanserin and the effectiveness of other serotonergic agents in alcoholism
pp. 160s-160s(1)
Authors: Boening J.; Wiesbeck G.A.

Opiate receptors: role in addiction and relapse in alcohol dependence
pp. 160s-161s(2)
Author: Chick J.D.

Increase in neuro-inhibitory amino-acids during alcoholization and in neuro-excitatory amino-acids during withdrawal
pp. 161s-161s(1)
Authors: De Witte P.; Dahchour A.

Different strategies of relapse prevention: a meta-analysis of drug efficiency
pp. 161s-161s(1)
Authors: Engel R.R.; Schochlin C.

Long-term follow-up of acamprosate treatment in alcoholic patients
pp. 161s-161s(1)
Author: Sass H.

Glutamatergic brain systems and addiction
pp. 162s-162s(1)
Authors: Zieglgansberger W.; Putzke J.; Spanagel R.

Perinatal psychiatry in France
pp. 162s-162s(1)
Authors: Sutter A.L.; Bourgeois M.L.

Transcultural aspects of perinatal psychiatry
pp. 162s-162s(1)
Author: Cox J.L.

Mental health services for women following childbirth
pp. 162s-163s(2)
Author: Oates M.R.

Perinatal care and maternal well-being in the Netherlands
pp. 163s-163s(1)
Author: Pop V.J.

Patients subjective experiences on anti-psychotic medications -- implications for outcome and quality of life
pp. 163s-163s(1)
Author: Awad A.G.

Neuroleptic-induced deficit syndrome, depression and negative symptoms in schizophrenia
pp. 163s-163s(1)
Authors: Barnes T.R.E.; McPhillips M.

Mental side effects and attitudes towards anti-psychotic medication
pp. 164s-164s(1)
Authors: Gerlach J.; Larsen E.B.

Patient requests and attitude towards neuroleptics
pp. 164s-164s(1)
Authors: Hoencamp E.; Knegtering H.; Kooij J.J.S.; van der Molen A.E.G.M.

Rating of subjective effects of antipsychotic drugs, relationships to objective psychopathology and quality of life
pp. 164s-164s(1)
Author: Naber D.

Epidemiology of sad and its subsyndromal form
pp. 164s-165s(2)
Authors: Kasper S.; Hesselmann B.; Neumeister A.; Rieder N.

Activity measurements in sad
pp. 165s-165s(1)
Authors: Koehler W.K.; Fey P.; Pflug B.

Involvement of the serotonergic system in the pathophysiology of SAD and light therapy
pp. 165s-165s(1)
Authors: Neumeister A.; Praschak-Rieder N.; Hesselmann B.; Rao M.L.; Kasper S.

Update on clinical aspects of SAD and light therapy
pp. 165s-165s(1)
Author: Rosenthal N.E.

The biology of seasonal affective disorder: are there winter summer differences?
pp. 165s-165s(1)
Authors: Thompson C.; Childs P.; Rodin I.; Martin N.

Neonatal neurological deviancy: neurological and behavioural sequelae during school-age and adolescence
pp. 166s-166s(1)
Author: Hadders-Algra M.

Interaction between biological and psychosocial risks in early development
pp. 166s-166s(1)
Authors: Schmidt M.H.; Esser G.; Laucht M.

Long-term behavioural, cognitive and neurological sequelae of prematurity
pp. 166s-166s(1)
Authors: Schothorst P.F.; van Engeland H.

Gofal celf -- ARTS CARE
pp. 166s-166s(1)
Author: Jones H.B.

Prospective of mental illness -- an art exhibition in the gorbals
pp. 166s-167s(2)
Author: Coia D.

House of artist in Gugging, near Vienna
pp. 167s-167s(1)
Author: Feilacher J.

Tate Gallery
pp. 167s-167s(1)
Author: Robertson P.

Depression after first myocardial infarction
pp. 167s-167s(1)
Authors: Honig A.; van Praag H.M.; Lousberg R.; Wojciechowski F.; Kuypers P.; Wellens H.

Prefrontal and anterior paralimbic dysfunction in primary and secondary mood disorders: evidence of common neural substrates
pp. 167s-168s(2)
Authors: Ketter T.A.; George M.S.; Kimbrell T.A.; Stein R.M.; Willis M.W.; Benson B.E.; Frye M.A.; Cora-Locatelli G.; Post R.M.

Depression and the postpartum patient
pp. 168s-168s(1)
Author: Steiner M.

Guidelines for C-L intervention in intensive care units
pp. 168s-168s(1)
Authors: European Consultation Liaison Workgroup; Cardoso G.; Tienari P.

The U.K. results of the European consultation liaison working group study
pp. 168s-168s(1)
Authors: Creed F.; Huyse F.; Herzog T.; Lobo A.; Malt U.

European standards for consultation liaison (CL) psychiatry and psychosomatics?
pp. 168s-169s(2)
Authors: European Consultation Liaison Workgroup ECLW; Herzog T.; Stein B.

Improvement of C-L services in Europe
pp. 169s-169s(1)
Authors: Huyse F.J.; Herzog T.; Lobo A.; Slaets J.P.

Guidelines for management of delirium: A critical review of clinical practice
pp. 169s-169s(1)
Author: van der Mast R.C.

The relationship between negative symptoms and tardive dyskinesia in schizophrenia
pp. 169s-169s(1)
Author: Cooper S.J.

Abnormal movements in never medicated Nigerian and Indian schizophrenic patients
pp. 169s-170s(2)
Authors: McCreadie R.G.; Thara R.

Comparative studies of abnormal involuntary movements in never-treated vs treated populations with schizophrenia
pp. 170s-170s(1)
Authors: Moussaoui D.; Fenn D.; Kadri N.; Green C.; Tilane A.; Bentounsi B.; Casey D.; Hoffman W.

The longitudinal association of cognitive dysfunction with tardive dyskinesia in schizophrenia
pp. 170s-170s(1)
Authors: Waddington J.L.; Youssef H.A.; O'Callaghan E.; Larkin C.

New aspects in the pharmacokinetics and metabolism of methadone
pp. 170s-171s(2)
Authors: Baumann P.; Eap C.B.; Finkbeiner T.; Lodemann E.; Bertschy G.

Ultra-rapid opiate detoxification: a clinical investigation
pp. 171s-171s(1)
Authors: Bertschy G.; Monnat M.; Cucchia A.T.

Buprenorphine in the treatment of opiate addiction
pp. 171s-171s(1)
Author: Reisinger M.

Mortality in the methadone-maintenance-program/nordrhein Westfalia, Germany
pp. 171s-171s(1)
Authors: Rosinger C.; Specka H.; Bender S.; Finkbeiner T.; Lodemann E.; Schall U.; Scherbaum N.; Gastpar M.

Providing mental health care for immigrants
pp. 171s-172s(2)
Author: Gailly A.

Psychopathology and migration: an epidemiological study
pp. 172s-172s(1)
Author: Mattia M.

Evidence for psychosis of good prognosis in people of caribbean origin living in the UK
pp. 172s-172s(1)
Authors: McKenzie K.; van Os J.; Jones P.; Murray R.; Fahy T.; Toone B.; Harvey I.

Refugee mental health in Europe: an overview of epidemiology and treatment interventions
pp. 172s-172s(1)
Authors: Pelosi A.J.; Duhod O.

High incidence of schizophrenia in Surinamese and Antillean immigrants to Holland
pp. 172s-173s(2)
Authors: Selten J.P.; Slaets J.P.J.

Differential aspects of impulsivity in patients with self mutilations
pp. 173s-173s(1)
Authors: Herpertz S.; Steinmeyer E.M.; Sass H.

Treatment of severe border-line personality disorders with special regard to borderline-syndromes: comparison of psychodynamic and behavioural therapy setup
pp. 173s-173s(1)
Authors: Mundt C.; Wahl R.; Hautzinger M.; Seidler G.; Keller A.; Burgy M.; Rotzoll M.; Lauer G.; Barnett W.

Borderline syndromes in adolescence
pp. 173s-173s(1)
Authors: Lehmkuhl G.; Berner W.

Abstract(s)
pp. 173s-174s(2)
Authors: Rechlin T.; Joraschky P.

Dissociative symptoms and self-mutilation in adolescent borderline personality disorder
pp. 174s-174s(1)
Authors: Resch F.; Brunner R.M.; Parzer P.; Koch E.

The genetics of handedness and its implications for pathology
pp. 174s-174s(1)
Author: Annett M.

Anatomical evidence for deviations in asymmetry
pp. 174s-175s(2)
Authors: Bogerts B.; Falkai

The origin of Schneiderian first-rank symptoms and the evolution of language
pp. 175s-175s(1)
Author: Crow T.J.

Patterns of hemisphere specialization as indicators of vulnerability to schizophrenia
pp. 175s-175s(1)
Authors: Maier W.; Gansicke M.; Franke P.; Falkai P.; Stoeter P.

Neuropsychological and clinical correlates of striatal asymmetry in schizophrenia
pp. 175s-175s(1)
Authors: Rossi A.; Stratta P.; Daneluzzo E.; Mattei P.; Bustini M.

Towards standard European measures of outcome
pp. 175s-176s(2)
Author: Marks I.M.

Group therapy for women with early stage breast cancer
pp. 176s-176s(1)
Author: Bloch S.

An integrated psychological treatment service as part of psychiatric services in a rural area
pp. 176s-176s(1)
Author: Holmes J.

The integral diagnostic and intervention schema: IDIS. A systematic approach towards consultations
pp. 176s-176s(1)
Author: Huyse F.J.

Helping carers of patients with severe mental illness
pp. 176s-177s(2)
Author: Szmukler G.I.

Psychological treatment of medically unexplained physical symptoms in a medical outpatient clinic
pp. 177s-177s(1)
Authors: Van Hemert A.M.; Speckens A.E.M.; Spinhoven P.; Hawton K.; Bolk J.

ICD-10 chapter V and DSM-IV: relationships between them, and comments upon similarities and differences
pp. 177s-177s(1)
Author: Cooper J.E.

Who ICD-10 evaluation and evolution: forensic implications
pp. 177s-177s(1)
Author: Cosyns P.

ICD-10 chapter V (F): difficulties and deficiencies
pp. 177s-178s(2)
Author: Dilling H.

Developmental aspects in the classification of mental and behavioral disorders
pp. 178s-178s(1)
Author: Rutter M.

The utility of measuring plasma levels of antidepressants in the treatment of affective disorders
pp. 178s-178s(1)
Authors: Ackenheil M.; Kuss H.-J.

Psychiatric classifications and diagnostic instruments in primary care settings
pp. 178s-178s(1)
Authors: Boyer P.; Weiller E.

The coprescription of psychotropic and somatic drugs with antidepressants
pp. 178s-178s(1)
Author: Rahola J.G.

The identification of psychiatric disorders in primary care
pp. 178s-179s(2)
Authors: Lecrubier Y.; Boyer P.; Lepine J.P.; Weiller E.

Psychotropic drug prescription in primary care
pp. 179s-179s(1)
Authors: Linden M.; Lecrubier Y.; Bellantuono C.; Benkert O.; Kisley S.; Simon G.

Sex differences in schizophrenia
pp. 179s-179s(1)
Author: Hafner H.

An epidemiological perspective on gender and mental health
pp. 179s-180s(2)
Author: Kastrup M.

Sex differences in alcoholism
pp. 180s-180s(1)
Authors: Mann K.; Ackermann K.; Jung M.; Mundle G.

Sociocultural factors and gender differences on mental health
pp. 180s-180s(1)
Authors: Vazquez-Barquero J.L.; de Santiago A.; Gaite L.; Herrera S.

The defeat depression campaign: interim results and future directions
pp. 180s-180s(1)
Author: Baldwin D.S.

Depres (depression patient research in european society): the patients' perspective of depression
pp. 180s-180s(1)
Author: Tylee A.

Aware of depression 10 years on: the Irish perspective
pp. 181s-181s(1)
Authors: McKeon P.; Gavigan P.; Garrick S.

Relationship between recognized depression and suicide in Hungary
pp. 181s-181s(1)
Author: Rihmer Z.

Lessons from the gotland study ''suicide and education -- effects, shortcomings, challenges''
pp. 181s-181s(1)
Authors: Rutz W.; Walinder J.; Piblgren H.; Von Knorring L.; Rihmer Z.

The hampshire depression project -- a model study of the effects of general practitioner education on the outcome of depression
pp. 181s-182s(2)
Authors: Thompson C.; Stevens L.; Peveler R.; Baldwin D.; Kinmonth A.L.; Stevens A.

Similarities and differences between schizophrenia and affective disorders
pp. 182s-182s(1)
Author: Bench C.J.

Functional brain imaging of negative symptoms of schizophrenia
pp. 182s-182s(1)
Authors: Martinot J.L.; Dao-Castellana M.H.; Artiges E.; Verdys M.; Paillere-Martinot M.L.; Levy D.; Poirier M.F.; Lecrubier Y.; Allilaire J.F.; Manus A.; Feline A.

Functional neuroanatomy of verbal self-monitoring
pp. 182s-183s(2)
Authors: McGuire P.K.; Silbersweig D.A.; Frith C.D.

Dopamine receptors and neurological side effects
pp. 183s-183s(1)
Authors: Nordstrom A.-L.; Farde L.

The sensorimotor cortex and supplementary motor area in schizophrenia: a study with functional magnetic resonance imaging
pp. 183s-183s(1)
Authors: Schroder J.; St. Frost; Schad L.R.; Gerdssen I.; Wenz F.; Baudendistel K.; Knopp M.V.

Passivity phenomena in schizophrenia
pp. 183s-183s(1)
Authors: Spence S.A.; Hirsch S.R.; Liddle P.F.; Meehan J.; Brooks J.D.; Grasby P.M.

Building an internationally-valid approach to economic evaluation
pp. 184s-184s(1)
Author: Knapp M.

Standardising measures of mental health service utilization
pp. 184s-184s(1)
Author: Knudsen H.C.

The consequences of psychiatric disorders for family members: a comparison between schizophrenia and depression
pp. 184s-184s(1)
Author: Schene A.H.

Two decades of evaluating targeted services in South-Verona
pp. 184s-185s(2)
Author: Tansella M.

True versus treated prevalence of psychosis -- the prism case identification study
pp. 185s-185s(1)
Authors: Thornicroft G.; Johnson S.

The concept of recovery in affective disorders
pp. 185s-185s(1)
Author: Fava G.A.

Psychotherapy and pharmacotherapy in anxiety disorders
pp. 185s-185s(1)
Author: Marks I.M.

Relapse and chronicity in depression
pp. 185s-186s(2)
Authors: Paykel E.S.; Ramana R.; Jenaway A.

Functional psychopathology and the diagnostic process in psychiatry
pp. 186s-186s(1)
Author: van Praag H.M.

Oestrogen may affect mood and mental state by an action on serotonin_2A receptors and serotonin transporter
pp. 186s-186s(1)
Authors: Fink G.; McQueen J.K.; Sumner B.E.H.; Rosie R.; Wilson H.

Suicide in young schizophrenic patients, a case control study
pp. 186s-187s(2)
Authors: De Hert M.; Peuskens J.

Long-term outcome of schizophrenia
pp. 187s-187s(1)
Author: Harrison G.

Predictors of long-term course in depressive illness
pp. 187s-187s(1)
Author: Lee A.

Long-term prognosis of uni- and bipolar disorders
pp. 187s-187s(1)
Authors: Marneros A.; Deister A.; Rohde A.

A thirty year follow-up of the newcastle affective disorders cohort
pp. 187s-187s(1)
Authors: Scott J.; Tacchi M.J.; Kerr A.

Long-term course in schizophrenia: predicting chronicity from a 15-years follow-up of an incidence cohort
pp. 188s-188s(1)
Authors: Wiersma D.; Nienhuis F.J.; Slooff C.J.; Giel R.; de Jong A.

The need for more psychiatric beds: a neoalienist perspective?
pp. 188s-188s(1)
Author: Coid J.

In defence of community and inpatient care
pp. 188s-189s(2)
Author: Kluiter H.

Hospital care: from sun to moon
pp. 189s-189s(1)
Author: Muijen M.

Community-based psychiatric care without back-up from the mental hospital a long-term experience
pp. 189s-189s(1)
Author: Tansella M.

What is the best way of delivering mental health care to the severely mentally ill?
pp. 189s-189s(1)
Author: Tyrer P.

HIV infection in psychiatric patients
pp. 190s-190s(1)
Authors: Ayuso-Mateos J.L.; Lastra I.; Montanes F.

Neuropsychiatric sequelae of HIV-1 infection: data from MRC cohort studies
pp. 190s-190s(1)
Authors: Baldeweg T.; Catalan J.; Gruzelier J.; Riccio M.; Hawkins D.

Substance-related disorders, psychopathology and HIV-related problems in Italy. A clinical research
pp. 190s-190s(1)
Authors: Clerici M.; Valsecchi P.; Sacchetti E.

Pathology of the central nervous system HIV infection
pp. 191s-191s(1)
Author: Gray F.

HIV infection in persons with haemophilia: a longitudinal study of psychological impact
pp. 191s-191s(1)
Authors: Marsettin E.P.; Ciavarella N.

Crisis Homes -- an emergency alternative to the hospital
pp. 191s-191s(1)
Author: Bennett R.

Mobile services: acute home-based care and community psychiatry. Results of a data analysis using the South Verona psychiatric case register
pp. 191s-192s(2)
Authors: Burti L.; Tansella M.

Cost benefit study of day care -- the effect of an attached community psychiatric nurse
pp. 192s-192s(1)
Author: Creed F.

From emergency to social psychiatric service centers; the Amsterdam experience
pp. 192s-192s(1)
Author: Gersons B.P.R.

Tensions and challenges in the provision of emergency mental health services
pp. 192s-192s(1)
Author: Phelan M.

Disability in the GB surveys of psychiatric morbidity
pp. 192s-193s(2)
Author: Jenkins R.

The development of European standards and assessment instruments for psychiatric disablements
pp. 193s-193s(1)
Author: Mavreas V.G.

Practical applications of ICIDH
pp. 193s-193s(1)
Author: Pull C.B.

Stress, corticosteroids and neuronal activity: effects of early life experience
pp. 193s-194s(2)
Authors: de Kloet E.R.; Workel J.O.; Rots N.Y.; Oitzl M.S.

Stress, corticosteroids and the genesis of depression
pp. 194s-194s(1)
Author: Dinan T.G.

Depression in late life and the ''glucocorticoid cascade'' hypothesis
pp. 194s-194s(1)
Author: O'Brien J.T.

The role of life events in senile dementia
pp. 194s-194s(1)
Authors: Orrell M.; Bebbington P.

The activity of corticotropin releasing hormone (CRH) neurons in the human hypothalmus in relation to aging, Alzheimer's disease and depression
pp. 194s-194s(1)
Authors: Swaab D.F.; Raadsheer F.C.; Lucassen P.J.; Hoogendijk W.J.G.; Tilders F.J.H.

The role of psychopharmacology in liaison psychiatry
pp. 195s-195s(1)
Author: Fava G.A.

Consultation liaison (CL) psychiatric and psychotherapy research: time as treatment variable
pp. 195s-195s(1)
Authors: European Liaison Workshop ECLW; Herzog T.; Stein B.

Psychotherapy in liaison psychiatry
pp. 195s-195s(1)
Author: Sharpe M.

Psychosis and behavioural disturbance in the elderly: prevalence, phenomenology, differential diagnosis
pp. 195s-196s(2)
Author: Aronson S.M.

Clinico-pathological correlations of the cognitive impairment in schizophrenia, treatment implications
pp. 196s-196s(1)
Authors: Davidson M.; Powchick P.; Davis K.L.

Antipsychotic drug treatment of late-life psychoses
pp. 196s-196s(1)
Authors: Jeste D.V.; Rockwell E.; Warren K.; Schalz A.; Nabatian I.; Naimark D.

Pharmacological management of psychosis in the face of dementia
pp. 196s-196s(1)
Author: Lawlor B.A.

The management of psychotic symptoms in dementia with lewy bodies (DLB)
pp. 196s-197s(2)
Authors: McKeith I.G.; Perry E.I.; Piggott M.A.; Perry R.H.

Physician assisted suicide: a round table debate
pp. 197s-197s(1)
Author: Berghmans R.L.P.

Physician assisted suicide: a round table discussion
pp. 197s-197s(1)
Author: Cosyns P.

Physician assisted suicide: a round table discussion
pp. 197s-197s(1)
Author: Kelleher M.J.

Physician assisted suicide: a round table debate legal developments in the Netherlands
pp. 198s-198s(1)
Author: Legemaate J.

Assisted suicide in psychiatry: clinical issues
pp. 198s-198s(1)
Author: Nolen W.A.

Readiness potential in catatonic syndromes
pp. 198s-198s(1)
Authors: Eckert J.; Northoff G.; Dierks T.; Maurer K.

Activation tasks and motor function in patients with neuroleptic-induced akathisia
pp. 199s-199s(1)
Authors: Gruber O.W.; Northoff G.

Dysfunction of supplementary motor area (SMA) in catatonia: motor activation studies with PET and F-MRI
pp. 199s-199s(1)
Authors: Northoff G.; Eckert J.; Hertel A.; Gille B.; Hacker H.; PFlug B.

Catatonia and extrapyramidal disorder
pp. 199s-199s(1)
Author: Rogers D.

Conceptual issues in catatonia research
pp. 199s-199s(1)
Authors: Ungvari G.S.; L. Y.C.

The revised ICD10-PHC classification
pp. 200s-200s(1)
Author: Goldberg D.

ICD-10 multiaxial presentation
pp. 200s-200s(1)
Authors: Janca A.; Kastrup M.; Katschnig H.; Lopez-Ibor J.J.; Mezzich J.E.; Sartorius N.

ICD-10 Casebook and Lexica
pp. 200s-200s(1)
Author: Pull C.B.

WHO ICD-10 evaluation and evolution: ICD-10 training courses
pp. 200s-200s(1)
Author: van Drimmelen-Krabbe J.J.

Behavioural treatments in obsessive compulsive disorder
pp. 200s-201s(2)
Author: Drummond L.M.

Refining the pharmacological treatment for obsessive compulsive disorder
pp. 201s-201s(1)
Authors: Fineberg N.A.; Roberts A.; Montgomery S.A.

Sleep patterns in OCD
pp. 201s-201s(1)
Authors: Okasha A.; Asaad T.

Body dysmorphic disorder and the relationship to OCD
pp. 201s-201s(1)
Author: Veale D.

Treatment of resistant OCD
pp. 201s-202s(2)
Authors: Zohar J.; Sasson Y.; Iancu I.

Movement disorders in schizophrenia and implications for the use of newer antipsychotics
pp. 202s-202s(1)
Author: Barnes T.R.E.

Dopamine and serotonin receptor occupancy in patients treated with antipsychotics
pp. 202s-202s(1)
Authors: Nordstrom A.-L.; Nyberg S.; Farde L.

Olanzapine versus haloperidol: results of the multi-center international trial
pp. 202s-203s(2)
Authors: Williamson D.J.; Beasley C.M.; Tran P.V.; Tamura R.N.; Sanger T.M.; Tollefson G.D.

Sweden's suicide prevention strategy
pp. 203s-203s(1)
Author: Beskow J.

England's suicide prevention strategy
pp. 203s-203s(1)
Authors: Jenkins R.; Kingdon D.

The Norwegian program for suicide prevention
pp. 203s-203s(1)
Author: Retterstol N.

Suicide rates of the elderly in Eastern Europe
pp. 203s-203s(1)
Author: Sartorius N.

Conceptualisation of schizophrenia: the symptom-oriented approach
pp. 204s-204s(1)
Author: Berner P.

Heterogeneity in schizophrenia: identifying subtypes by cluster analyses
pp. 204s-204s(1)
Authors: Dollfus S.; Brazo P.

The deficit syndrome of schizophrenia: towards heterogeneity of schizophrenia?
pp. 204s-204s(1)
Authors: Petit M.; Thibaut F.; Ribeyre J.M.

Factor analysis and structural models of schizophrenia
pp. 204s-204s(1)
Author: White L.

Behavioural assessment of memory in normal old age
pp. 205s-205s(1)
Author: Cockburn J.M.

A longitudinal study of behaviour in dementia
pp. 205s-205s(1)
Authors: McShane R.; Hope T.

Evidence based psychiatry and the cochrane collaboration
pp. 205s-205s(1)
Author: Adams C.

Meta-analysis using individual patient data
pp. 205s-205s(1)
Author: Bech P.

Systematic reviews -- theory and practice. SSRI's and tricyclics for the treatment of depression
pp. 205s-206s(2)
Authors: Churchill R.; Hotopf M.; Hardy R.; Lewis G.; Normand C.

Changes in 5-HT receptor sensitivity during treatment with SSRIs: implications for mode of action
pp. 206s-206s(1)
Author: Cowen P.J.

Tolerability and safety of novel antidepressants
pp. 206s-206s(1)
Author: Freeman H.

New trends in the pharmacological treatment of depression
pp. 206s-207s(2)
Author: Leonard B.E.

Mirtazapine
pp. 207s-207s(1)
Author: Nutt D.J.

Therapeutic aspects of depression in epilepsy: the impact of drug interactions
pp. 207s-207s(1)
Author: Monaco F.

Therapeutic aspects of depression and epilepsy: new vs. old antiepileptic drugs
pp. 207s-207s(1)
Author: Pisani F.

Depression in people with eplilepsy
pp. 207s-208s(2)
Author: Robertson M.M.

Therapeutic aspects of depression and epilepsy: new vs. old antidepressant drugs
pp. 208s-208s(1)
Authors: Torta R.; Borio R.; Cicolin R.A.; Monaco F.; Ravizza L.

Forced normalisation and its relevance for neuropsychiatry
pp. 208s-208s(1)
Author: Trimble M.R.

Prevention of depression and suicide in primary care
pp. 208s-208s(1)
Authors: Rutz W.; Walinder J.; von Knorring L.; Pihlgren H.; Rihmer Z.

Experimental models of anxiety
pp. 209s-209s(1)
Authors: Deakin J.F.W.; Connell J.; Anderson I.M.; Miller H.

Serotonergic and cholecystokininergic challenges in panic disorder
pp. 209s-209s(1)
Authors: Den Boer J.A.; Van Megen H.J.G.M.; Westenberg H.G.M.

Imaging studies in anxiety disorders
pp. 209s-209s(1)
Authors: Nutt D.J.; Malizia A.L.

Challenge studies in obsessive compulsive disorder: recent developments with MCPP and pentagastrin
pp. 210s-210s(1)
Authors: Westenberg H.G.M.; K.L. Ho P.; de Leeuw A.S.; den Boer J.A.

Obstetric complications and premorbid cognitive and social adjustment in schizophrenics and their same-sex unaffected siblings
pp. 210s-210s(1)
Authors: Willinger U.; Heiden A.M.; Meszaros K.; Aschauer H.N.

Obstetric complications and prenatal maldevelopment: results from Swedish studies
pp. 210s-210s(1)
Authors: Cantor-Graae E.; McNeil T.F.

Dermatoglyphics and schizophrenia: recent studies in samples from britain and spain
pp. 211s-211s(1)
Author: Fananas L.

Obstetric complications and schizophrenia: a scottish case control study based on standardised obstetric records
pp. 211s-211s(1)
Authors: Kendell R.E.; Juszczak E.; Cole S.

Minor physical anomalies in schizophrenia: introduction to a new metric scale and results in samples from Ireland
pp. 211s-211s(1)
Author: Lane A.

International collaborative study of the association between schizophrenia and obstetric complications. Relationships between obstetric complications, age at onset, gender, and family history
pp. 211s-211s(1)
Author: Verdoux H.

Depression, physical health and disability in later life: a pragmatic approach based on the findings of the longitudinal aging study amsterdam (LASA)
pp. 212s-212s(1)
Authors: Beekman A.T.F.; Deeg D.J.H.; Tilburg W.V.

Short evaluations of depression in the elderly: issues for general practice
pp. 212s-212s(1)
Authors: Clement J.P.; Leger J.M.; Nassif F.; Paulin S.

Treatment of child-abuse in Germany and Austria
pp. 212s-212s(1)
Author: Berner W.

Treatment of sexual abusers in Belgium
pp. 212s-213s(2)
Author: Cosyns P.

Sexual offenders: treatment, punishment or both?
pp. 213s-213s(1)
Author: Grubin D.

The sliding scale: treatment of sex offenders in the Netherlands
pp. 213s-213s(1)
Author: van Marle H.

Membranes and psychiatric disorders
pp. 213s-213s(1)
Authors: Glen A.I.M.; Horrobin D.F.

A genetic abnormality in schizophrenia related to phospholipase A2
pp. 213s-214s(2)
Authors: Hudson C.J.; Kennedy J.L.; Horrobin D.F.

Schizophrenic symptoms and dietary intake of N-3 fatty acids
pp. 214s-214s(1)
Authors: Mellor J.E.; Laugharne J.D.E.; Peet M.

The relationship between plasma fatty acid concentrations and movement disorders
pp. 214s-214s(1)
Author: Nilsson A.

'Minders' -- A TV year with a CMHT
pp. 214s-214s(1)
Author: Burns T.

The psychiatrist as media interviewer -- finding the limits
pp. 214s-215s(2)
Author: Clare A.

Between anxiety and aggression, physiological and psychosocial effects of television violence
pp. 215s-215s(1)
Author: Grimm J.

Flirting with the media -- should psychiatry marry or divorce a fickle temptress?
pp. 215s-215s(1)
Author: Persaud R.A.J.

WHO-ICD 10 evaluation and evolution: SCAN status
pp. 216s-216s(1)
Author: Brugha T.S.

IPDE status
pp. 216s-216s(1)
Authors: Janca A.; Loranger A.; Sartorius N.

Towards a common language for the assessment of disablements: ICIDH
pp. 216s-216s(1)
Author: Ustun T.B.

The WHO-composite international diagnostic interview (CIDI): current status and the future
pp. 216s-217s(2)
Author: Wittchen H.U.

The information superhighway and psychiatry
pp. 217s-217s(1)
Author: Briscoe M.

Internet perspectives for psychiatry
pp. 217s-217s(1)
Authors: Malchow C.P.; Kanitz R.D.

Computerized audit of clinical outcome and its cost: a european clearinghouse is now possible
pp. 217s-217s(1)
Author: Marks I.M.

Frontolimbic mechanisms for perceptual and response classification in schizophrenia
pp. 217s-218s(2)
Authors: Bilder R.M.; Turkel E.; Bates J.A.; Lieberman J.A.

Shape perception in schizophrenia: EEG analysis of a cortical activation task
pp. 218s-218s(1)
Author: Gallhofer B.

Towards an understanding of the cognitive basis of delusion formation in schizophrenia using visual scan paths
pp. 218s-218s(1)
Authors: Phillips M.L.; David A.S.

The historical background and cognitive neuroscience of perceptual processes in psychosis
pp. 218s-218s(1)
Author: Spitzer M.

Visual scanning strategies and cognitive dysfunctions in a visuomotor tracking task in the course of schizophrenia
pp. 218s-219s(2)
Authors: Wolwer W.; Streit M.; Gaebel W.

Moclobemide: a paradigm of research in clinical psychopharmacology
pp. 219s-219s(1)
Authors: Angst J.; Amrein R.; Stagbl M.

The history of Tacrine in the treatment of Alzheimer's Disease
pp. 219s-219s(1)
Author: Eagger S.A.

The rise and fall of the benzodiazepines
pp. 219s-219s(1)
Author: Lader M.H.

Clozapine -- the fall and rise of an antipsychotic
pp. 219s-220s(2)
Author: Naber D.

Some attempts to generate outcome measures in the treatment of anorexia nervosa
pp. 220s-220s(1)
Authors: Hall P.; Robertson D.; Whitehouse P.; Wiesden Y.; Gough H.

Weight aspects in anorexia nervosa
pp. 220s-220s(1)
Authors: Hebebrand J.; Remschmidt H.

Risk factors for eating disorders: differences in incidence rates in relation to urbanization and culture
pp. 220s-220s(1)
Authors: Hoek H.W.; van Hoeken D.

Towards psychotherapy for eating disorders of high quality and affordable costs
pp. 221s-221s(1)
Authors: German Collaborative Study Group on Eating Disorders; Kordy H.

Utilisation of psychiatric beds in the treatment of ICD-8 eating disorders in Denmark 1970-1993, a register study
pp. 221s-221s(1)
Authors: Nielsen S.; Moller-Madsen S.; Nystrup J.

Testing candidate gene hypotheses in schizophrenia
pp. 221s-221s(1)
Authors: Gill M.; Hawi Z.; Gibson S.; Kendler K.; Straub R.; Walsh D.

Anticipation in schizophrenia: new light on a controversial problem
pp. 221s-222s(2)
Authors: Gorwood P.; Leboyer M.; Falissard B.; Jay M.; Rouillon F.; Feingold J.

The ESF programme on the molecular neurobiology of mental illness. Progress and preliminary findings
pp. 222s-222s(1)
Author: McGuffin P.

Psychopathology and biological research
pp. 222s-222s(1)
Author: Barocka A.

Psychopathology -- future aspects
pp. 222s-222s(1)
Author: Berner P.

Definitions of psychopathology
pp. 222s-222s(1)
Author: Musalek M.

The psychopathological basis for research and practice
pp. 222s-223s(2)
Author: Sims A.

Anthropological perspectives in psychopathology
pp. 223s-223s(1)
Author: Stanghellini G.

Behavioral phenotypes in children and adolescents with Prader-Willi syndrome and Williams-Beuren syndrome
pp. 223s-223s(1)
Authors: Curfs L.M.G.; van Lieshout C.F.M.; Fryns J.P.

Regional survey of adults with learning disabilities (mental retardation) receiving depot neuroleptics: drug usage in those with challenging behaviours
pp. 223s-223s(1)
Author: Gravestock S.M.

Stereotypies and self-injurious behavior; the pathogenetic role of stress hormones and serotonergic variables
pp. 223s-224s(2)
Authors: Tuinier S.; Verhoeven W.M.A.

Diagnostic backgrounds of severe behavioral disorders in persons with learning disabilities
pp. 224s-224s(1)
Authors: Verhoeven W.M.A.; Tuinier S.

Positive melancholia and the philosophic temperament
pp. 224s-224s(1)
Author: Bech P.

Interpersonal processes and brain sciences -- a new anthropology
pp. 224s-224s(1)
Author: McClelland R.J.

Neuropsychiatry and the unconscious free will
pp. 224s-225s(2)
Author: Spence S.A.

Neurocomputal models of psychopathology: what can we learn?
pp. 225s-225s(1)
Author: Spitzer M.

''Brute facts''
pp. 225s-225s(1)
Author: Wilkes K.V.

The pharmaco-economics of schizophrenia: new horizons
pp. 225s-225s(1)
Authors: Aitchison K.J.; Kerwin R.W.

Antipsychotic drugs: the current limitations and future promises
pp. 225s-226s(2)
Author: Lieberman J.A.

Hope for a new beginning
pp. 226s-226s(1)
Authors: Schiller L.; Schiller N.

The use of cognitive behaviour therapy in the treatment of schizophrenia
pp. 226s-226s(1)
Author: Tarrier N.

Effects of pharmacological manipulations of 5-HT2A and glycine receptors in a mouse model of hypoglutamatergia
pp. 227s-227s(1)
Authors: Carlsson M.L.; Carlsson A.

Review of dopamine D2/5HT2 blockers
pp. 227s-227s(1)
Author: Gerlach J.

Antipsychotics -- the next generation
pp. 227s-227s(1)
Author: Iversen S.D.

The 5HT2 receptor as a site for antipsychotics
pp. 227s-227s(1)
Author: Kerwin R.

Quality of life in anxiety
pp. 228s-228s(1)
Author: Angst J.

The validity of quality of life measurements in major depression
pp. 228s-228s(1)
Author: Bech P.

Quality of life instruments in schizophrenia: a comperative study
pp. 228s-228s(1)
Authors: Bobes J.; Gonzalez M.P.; Wallace D.H.; Bousono M.; Saiz P.

Quality of life: the WHOQOL
pp. 228s-228s(1)
Author: Orley J.

Quality of life in psychiatry
pp. 228s-229s(2)
Author: Sartorius N.

Neurodevelopmental model(s) of schizophrenia and approaches to their validation
pp. 229s-229s(1)
Authors: Keshavan M.S.; Pierri J.

Loss of developmental torque in familial schizophrenia -- a volumetric magnetic resonance imaging study using unbiased stereology
pp. 229s-229s(1)
Authors: Sharma T.; Sigmundsson T.; Lewis S.; Lancaster E.; Barta P.; Pearlson G.; Gurling H.; Murray R.

A pet study of word generation in obligate carriers of the predisposition to schizophrenia
pp. 229s-229s(1)
Authors: Spence S.; Sharma T.; Hellewell J.; Stefan M.; McGuire P.; Grasby P.; Deakin W.; Murray R.; Friston K.; Frith C.; Liddle P.

Schizophrenics and their adopted-away offspring. The finnish adoptive family study of schizophrenia
pp. 229s-230s(2)
Authors: Tienari P.; Wynne L.C.; Laksy K.; Sorri A.; Lahti I.; Moring J.; Wahlberg K.-E.

Brain morphology in familial and sporadic schizophrenia
pp. 230s-230s(1)
Authors: Vita A.; Dieci M.; Giobbio G.M.

Media violence and adolescent developmental issues
pp. 230s-230s(1)
Author: Barbosa A.

Bullying: the violence in peer groups
pp. 230s-231s(2)
Author: Dabkowski M.

When pregnancy becomes a source of violence
pp. 231s-231s(1)
Authors: Danion-Grilliat A.; Becache E.; Vincendon A.G.; Burstejn C.

Infanticide
pp. 231s-231s(1)
Author: Kumar R.

Attempted suicide and psychic trauma in adolescence
pp. 231s-231s(1)
Author: Ladame F.

PET D₁-receptor studies in schizophrenia
pp. 231s-232s(2)
Authors: Karlsson P.; Farde L.; Halldin C.; Sedvall G.

5HT2 receptor measurement in schizophrenia by PET
pp. 232s-232s(1)
Authors: Trichard C.; Paillere-Martinot M.L.; Attar-Levy D.; Recassens C.; Monnet F.; Blin J.; Martinot J.L.

The impact of in vivo receptor PET measurement on neuropharmacology
pp. 232s-233s(2)
Author: Nyberg S.

In vivo receptor spet studies of antipsychotic drug action
pp. 233s-233s(1)
Authors: Pilowsky L.S.; Busatto G.F.; Costa D.C.; Gacinovic S.; Ell P.J.; Kerwin R.W.

Epidemiology of sexual problems and dysfunctions in the community
pp. 233s-233s(1)
Authors: Angst J.; Degonda M.

Cerebral ventricle dimensions as risk factors for schizophrenia and affective psychosis: an epidemiological approach to analysis
pp. 233s-233s(1)
Authors: Jones P.B.; Harvey I.; Lewis S.W.; Toone B.K.; Van Os J.; Williams M.; Murray R.M.

Genetic epidemiology of functional psychoses
pp. 233s-234s(2)
Author: Maier W.

New perspectives on the clinical epidemiology of schizophrenia
pp. 234s-234s(1)
Authors: Nowotny B.; Hafner H.

Buprenorphine in the treatment of opiate addiction. European status
pp. 234s-234s(1)
Author: Auriacombe M.

Delivery of methadone maintenance in the European Union
pp. 234s-234s(1)
Authors: Farrell M.; Neeleman J.; Gossop M.; Griffiths P.; Finch E.; Strang J.

Methadone maintenance or withdrawal: how realistic is it to conduct a controlled trial?
pp. 234s-235s(2)
Authors: Finch E.J.L.; Strang J.; Hankinson L.; Gossop M.; Farrell M.; Taylor C.

Commonalities in methadone substitution therapy programmes in Europe: a case for a unified policy?
pp. 235s-235s(1)
Authors: Ghodse A.H.; Clancy C.; Oyefeso A.

The role pharmacokinetics and psychopathology in the prediction of craving among opiate addicts in methadone maintenance therapy
pp. 235s-235s(1)
Authors: van den Brink W.; de Vos J.W.

A historical note on the development of zimelidine, the first selective serotonin reuptake inhibitor
pp. 235s-236s(2)
Author: Carlsson A.

The invention of antidepressants
pp. 236s-236s(1)
Author: Healy D.

Thioxanthene antipsychotics
pp. 236s-236s(1)
Author: Pedersen V.

The beginning of psychopharmacology: deep-sleep therapies
pp. 236s-236s(1)
Author: Shorter E.

Diagnosis of the narcoleptic syndrome
pp. 236s-237s(2)
Authors: Dahlitz M.J.; Parkes J.D.

Sleep, offending and the law
pp. 237s-237s(1)
Author: Fenwick P.

Hypnotics and daytime performance
pp. 237s-237s(1)
Author: Hindmarch I.

The pharmacology and therapeutics of sleep
pp. 237s-237s(1)
Author: Lader M.H.

Normal sleep physiology
pp. 237s-238s(2)
Author: Roth T.

Attachment patterns (APs) and defense mechanisms (DMs) in personality disorders (PDs): a preliminary study
pp. 238s-238s(1)
Authors: Barone L.; Lingiardi V.; Maffei C.

Psychodynamic conflicts in DSM-III-R personality disorders
pp. 238s-238s(1)
Authors: Guldberg C.A.; Dramsdahl E.; Dahl A.A.

Clinical assessment of defense mechanisms using the defense mechanism rating scale (DMRS) by J.C. Perry
pp. 238s-239s(2)
Authors: Lingiardi V.; Vanzulli L.; Simula M.; Lonati C.; Fossati A.; Maffei C.

Categorical and dimensional assessment of personality disorders: an integrative approach
pp. 239s-239s(1)
Authors: Sass H.; Herpertz S.; Houben I.; Steinmeyer E.M.

Impulsive behaviour and genes implicated in serotonin neurotransmission: an association study
pp. 239s-239s(1)
Authors: Staner L.; Pull M.C.; Cloos I.M.; Stefos G.; Pull C.B.

Studying the effects of dopamine neurotransmission with functional imaging
pp. 239s-239s(1)
Author: Dolan R.J.

The future of functional imaging in psychiatry
pp. 239s-240s(2)
Author: Grasby P.M.

Magnetic resonance spectroscopy (MRS) as a tool to study the neuropathology of schizophrenia
pp. 240s-240s(1)
Authors: Ron M.A.; Maier M.

Risk of traffic accident injury after benzodiazepine use
pp. 240s-240s(1)
Author: Neutel C.I.

Role of benzodiazepine comedication in determining depressed patients driving performance during antidepressant (fluoxetine and moclobemide) therapy: results of a post hoc analysis
pp. 240s-240s(1)
Authors: Ramaekers J.G.; Ansseau M.; Muntjewerff N.D.; Sweens P.; O'Hanlon J.F.

Benzodiazepine and tricyclic antidepressant use and motor vehicle crash risk among older drivers
pp. 241s-241s(1)
Author: Ray W.A.

Effects or alpidem, lorazepam and placebo on actual driving performance of anxious patients
pp. 241s-241s(1)
Authors: Vermeeren A.; Swijgman H.F.; O'Hanlon J.F.

A double-blind study of the therapeutic effects of chronically administered buspirone and diazepam and their effects on actual driving performance in outpatients with generalized anxiety disorder
pp. 241s-241s(1)
Authors: van Laar M.W.; Volkerts E.R.

Does schizophrenia result from pregnancy, delivery and perinatal complications? A 28 year study in the 1996 North Finland birth cohort
pp. 242s-242s(1)
Authors: Jones P.; Rantakallio P.; Hartikainen A.-L.; Isohanni M.; Sipila P.

A comparative norwegian psychiatric epidemiological study
pp. 242s-242s(1)
Authors: Kringlen E.; Torgersen S.

Personality and low IQ as possible risk factors for schizophrenia
pp. 242s-242s(1)
Authors: Lewis G.; David A.; Malmberg A.; Allebeck P.

The danish database for psychiatric epidemiological research
pp. 242s-242s(1)
Author: Bo Mortensen P.

Personality disorders among criminal offenders from East London: an analysis of consecutive psychiatric assessments 1987-95
pp. 242s-243s(2)
Author: Coid J.W.

Serotonergic function in personality disordered offenders
pp. 243s-243s(1)
Author: Dolan M.

Impulsivity and aggression in patients with self-destructive behavior and their relation to serotonergic dysfunction
pp. 243s-244s(2)
Authors: Herpertz S.; Sass H.

Personality disorders among criminal offenders: an analysis of 1498 consecutive forensic psychiatric investigations
pp. 244s-244s(1)
Authors: Kullgren G.; Grann M.; Holmberg G.

The impact of personality disorders for the prognosis of delinquency
pp. 244s-244s(1)
Author: Nedopil N.

Verbal working memory: an fMRI activation paradigm for investigating schizophrenia
pp. 244s-244s(1)
Authors: Mellers J.D.C.; Bullmore E.; Brammer M.; Williams S.C.R.; Andrew C.; Simmons A.; Woodruff P.; David A.; Howard R.

Supplementary motor area (SMA) during motor activation of catatonic patients in functional MRT
pp. 245s-245s(1)
Authors: Northoff G.; Khoram-Sefat D.; Herrig M.; Eckert J.; Hacker H.; Pflug B.; Maurer K.

Functional magnetic resonance imaging of frontal cortical activation in a working memory task
pp. 245s-245s(1)
Authors: Spitzer M.; Kammer T.; Bellemann M.E.; Guckel F.; Brix G.

Learning studies with functional MRI
pp. 245s-245s(1)
Author: Turner R.

Right frontal hypoperfusion in schizophrenics while performing the Wisconsin card sorting test -- a functional MRI study
pp. 245s-246s(2)
Authors: Volz H.-P.; Gaser C.; Hager F.; Kaiser W.A.; Sauer H.

Auditory hallucinations in schizophrenia alter cortical response to externally presented speech- an fMRI study
pp. 246s-246s(1)
Authors: Woodruff P.W.R.; Wright I.; Brammer M.; Howard R.; Shapleski J.; Rossell S.; David A.S.; Bullmore E.; Mellers J.D.C.; Andrew C.; Simmons A.; Williams S.C.R.

Measurement of anhedonia: a review of the instruments
pp. 246s-246s(1)
Author: D'haenen H.

Anhedonia in chronic schizophrenia: a specific dimension?
pp. 246s-247s(2)
Authors: Loas G.; Noisette C.; Legrand A.; Boyer P.

Cognitive deficits related to anhedonia
pp. 247s-247s(1)
Authors: Pierson A.; Jouvent R.

A new scale for measurement of hedonic tone
pp. 247s-247s(1)
Author: Snaith R.P.

Anhedonia in depression: state or trait
pp. 247s-247s(1)
Author: Willner P.

Where should we go from here?
pp. 247s-248s(2)
Author: Caldicott F.

Psychiatric education in europe. Introduction
pp. 248s-248s(1)
Author: Christodoulou G.N.

Present state of postgraduate psychiatric education in EU countries
pp. 248s-248s(1)
Author: Gomez-Beneyto M.

Training in psychiatry in europe -- recommendations of the european board of psychiatry
pp. 248s-248s(1)
Author: Hohagen F.

The outcome of depression in Europe: the effect of person centred prevention in urban and rural settings
pp. 248s-249s(2)
Author: Dowrick C.

Methology and practice of the psychotherapy measurement effects in neurotic disorders
pp. 249s-249s(1)
Authors: Aleksandrovic J.; Mazgaj M.D.D.

Criteria of efficacy in psychotherapy. Application to psychosis
pp. 249s-249s(1)
Authors: Cremniter D.; Batista G.

Causative factors in the psychotherapy of depression
pp. 249s-249s(1)
Author: Mundt C.

The question of efficacy in the history of psychotherapy
pp. 249s-249s(1)
Author: Peters U.H.

Impact of treatment on the core deficit pathology
pp. 251s-251s(1)
Author: Carpenter W.T.

Effects of acute tardive EPS on outcome
pp. 251s-251s(1)
Author: Gerlach J.

Effect of non-pharmacologic interventions on outcomes
pp. 251s-252s(2)
Author: Littrell K.

Impact of olanzapine on quality of life in schizophrenia
pp. 252s-252s(1)
Author: Martin C.

Biological and social predictions of outcome in psychosis
pp. 252s-252s(1)
Author: Murray R.M.

The synergistic benefits of serotonin and noradrenaline reuptake inhibition
pp. 252s-252s(1)
Author: Nelson J.C.

Expanding applications for venlafaxine, a dual action antidepressant in clinical medicine
pp. 252s-253s(2)
Author: Priest R.

A clinical perspective on the therapeutic role of venlafaxine, a SNRI, in depression
pp. 253s-253s(1)
Author: Salinas E.

Dopamine and the use of SSRIs for conditions other than depression
pp. 253s-253s(1)
Author: Hale A.S.

SSRI's and movement disorders: is serotonin the culprit?
pp. 253s-254s(2)
Authors: Leonard B.E.; Faherty C.

Serotonin and the extrapyramidal system -- a neurological perspective
pp. 254s-254s(1)
Author: Meara R.J.

Serotonin central synaptic transmission and the regulation of the extrapyramidal system: the psychiatric perspective
pp. 254s-254s(1)
Author: Ring H.

Human brain imaging -- a force for psychiatry and psychopharmacology
pp. 255s-255s(1)
Author: Sedvall G.

Integrating Eastern Europe
pp. 255s-255s(1)
Author: Sartorius N.

Lithium prophylaxis of bipolar disorder: long-term outcome in ordinary clinical conditions
pp. 255s-256s(2)
Author: Maj M.

Drug treatment for anxiety disorders: a legacy of William Sargant
pp. 256s-256s(1)
Author: Gelder M.G.

Nosologo-mania and comorbidity in psychiatry
pp. 256s-256s(1)
Author: Angst J.

Clinical practice guidelines workshop
pp. 257s-257s(1)
Author: Palmer C.

Normal planum temporale asymmetry in familial schizophrenia: a volumetric MRI study
pp. 259s-259s(1)
Authors: Frangou S.; Sharma T.; Barta P.; Pearlson G.; Murray R.M.

A monozygotic schizophrenic triplet
pp. 259s-259s(1)
Authors: Harnryd C.; Jonsson E.; Greitz D.; Johannesson T.; Nyman H.; Wahlstrom J.; Sedvall G.

Neuroimaging findings in patients with postpartum psychoses
pp. 259s-259s(1)
Authors: Lanczik M.; Fritze J.; Hofmann E.; Schulz C.; Becker T.

Simple schizophrenia revisited: a clinical, neuropsychological and brain imaging analysis
pp. 259s-260s(2)
Authors: Serra-Mestres J.; Gregory C.; Tandon S.; McKenna P.J.

Quantitative EEG in medicated and unmedicated schizophrenics: evidence for hyper-stabilized brain function
pp. 260s-260s(1)
Authors: Stevens A.; Spandl C.; Bartels M.

Regional cerebral activation during word production in negative schizophrenia
pp. 260s-260s(1)
Authors: Verdys M.; Artiges E.; Manus A.; Feline A.; Poirier M.F.; Paillere-Martinot M.L.; Leborgne M.; Tzourio N.; Di Giamberardino L.; Martinot J.L.

Limbic system dysfunctions in mania and schizophrenia using ¹⁸F-fluorodeoxyglucose and positron emission tomography
pp. 260s-261s(2)
Authors: Al-Mousawi A.H.; Evans N.; Roeda D.; Chaloner F.; Ashcroft G.W.

Anger and sadness: a pet study of affective memory
pp. 261s-261s(1)
Authors: Baker S.C.; Shaw S.; Frith C.D.; Checkley S.A.; Dolan R.J.

A selective interhemispheric transfer callosal deficit in autism
pp. 261s-261s(1)
Authors: Gruzelier J.H.; Stevens S.; Lewis K.

D2 dopamine receptor binding before and after treatment of major depression measured by single photon emission computed tomography
pp. 261s-261s(1)
Authors: Klimke A.; Larisch R.; Loffler S.; Vosberg H.; Muller-Gartner H.W.; Gaebel W.

Retrograde amnesia in patients with temporal lobe, frontal lobe and diencephalic lesions
pp. 261s-262s(2)
Authors: Kopelman M.D.; Stanhope N.

Psychiatric illness one year following head injury
pp. 262s-262s(1)
Authors: Lyons I.; Koutzoukis C.; Deb S.

Affective disorder, temporal lobe symptomatology and migraine. A study of migraine clinic attenders
pp. 262s-262s(1)
Authors: McEvedy C.J.B.; Gene-Cos N.; Bench C.J.; Steiner T.J.; Barnes T.R.E.

A neuropsychological and SPECT study of epilepsy and schizophrenia
pp. 262s-262s(1)
Authors: Mellers J.D.C.; Toone B.K.; Lishman W.A.

Social networks, service utilisation and service costs in South London
pp. 263s-263s(1)
Authors: Becker T.; McCrone P.; Thornicroft G.; Loftus L.; Leese M.; Johnson S.; Turner D.

Why psychiatrists frequently fail adult survivors of childhood sexual abuse
pp. 263s-263s(1)
Author: Caplan R.P.

Controlling psychiatric inpatients: the response of staff to patient misdemeanour
pp. 263s-263s(1)
Author: Crichton J.H.M.

Intensive case management: does it work?
pp. 263s-264s(2)
Authors: Holloway F.; Carson J.

Quality management in community mental health care of chronically mentally ill people
pp. 264s-264s(1)
Authors: Langle G.; Gunthner A.; Buchkremer G.

Quality of life in chronic mental illness: theoretical models, empirical findings and implications for future research
pp. 264s-264s(1)
Authors: Lauer G.; Weisbrod M.; Maier S.; Kleine M.; Bahr F.

Falling through the net: discrepancies between community mental health services and primary care services in care plans for patients recently discharged from a community mental health team
pp. 264s-264s(1)
Authors: Lucas B.B.; Harrison-Read P.

Utilization of homecare support systems as a function of the burden on caregiving relatives: alzheimer's disease versus vascular dementia
pp. 264s-264s(1)
Authors: Vetter P.; Kraus S.; Steiner O.; Kropp P.; Moller W.D.

Psychiatric morbidity in primary health care. Prevalene, hidden psychiatric morbidity and treatment. A scandinavian multicentre investigation
pp. 265s-265s(1)
Authors: Fink P.; Borgquist L.; Brevik J.I.; Dalgard O.S.; Engberg M.; Hansson L.; Holm M.; Jensen J.; Joukamaa M.; Karlsson H.; Lehtinen V.; Munk-Jorgensen P.; Nettelbladt P.; Nordstrom G.; Sandager I.; Stefansson C.G.; Sorensen L.

Soviet mentality and psychiatric diagnosis: some semantic and semiotic aspects
pp. 265s-265s(1)
Author: Gerulaitiene D.M.

Cross-cultural study of psychological distress among ethiopian and russian immigrants to Israel
pp. 265s-265s(1)
Authors: Ginath Y.; Vendiamino B.; Safro S.; Ponizovsky A.; Durst R.; Ritsner M.

Psychiatric disorders among migrants: correlation between psychopathology and psychopharmacology
pp. 265s-266s(2)
Author: Haasen C.

Why do doctors prescribe psychoactive drugs in primary care? Results of an international study
pp. 266s-266s(1)
Authors: Kisely S.; Linden M.; Bellantuono C.; Simon G.

Diagnosis and treatment of psychiatric disorders in primary health care
pp. 266s-266s(1)
Authors: Kleinschmidt S.; Schurmann A.; Mussigbrodt H.; Dilling H.

Do general practitioners discriminate against patients with schizophrenia?
pp. 266s-267s(2)
Author: Lawrie S.M.

Psychiatry in Trinidad and Tobago: a review
pp. 267s-267s(1)
Author: Parasram R.

The prognosis of depression in old age: the Melbourne study
pp. 267s-267s(1)
Authors: Ames D.; E. C.; Bennetts K.; Allen N.; Layton T.; Kingston K.; Harrigan S.; Yeatman R.; Ruth P.; Kramer L.

Is depression treatable in a disabled elderly population? A randomised controlled trial
pp. 267s-267s(1)
Authors: Banerjee S.S.; Shamash K.; Macdonald A.J.D.; Mann A.H.

Thyroxine augmentation of fluoxetine treatment for resistant depression in the elderly: an open trial
pp. 267s-268s(2)
Authors: Barak Y.; Stein D.; Levine J.; Ring A.; Chadjez J.; Elizur A.

Age & sex specific incidence rates for dementia in a sample of community elderly with confirmation after a further two years
pp. 268s-268s(1)
Author: Copeland J.R.M.

One hundred cases of attempted suicide in the elderly. A three and a half year outcome study of mortality and morbidity
pp. 268s-268s(1)
Authors: Hepple J.; Quinton C.

Depression, ''pseudo-dementia'' and dementia in the elderly. A cross sectional study of distribution and risk factors
pp. 268s-268s(1)
Authors: Morawetz C.; Stevens A.

Recognition of dementia and depression in primary care
pp. 269s-269s(1)
Authors: Stoppe G.; Sandholzer H.; Staedt J.; Winter S.; Kiefer J.; Ruther E.

Presenile dementia in Scotland: a clinical and genetic analysis
pp. 269s-269s(1)
Authors: Woodburn K.J.; Johnstone E.

Does brief dynamic psychotherapy reduce the relapse rate of panic disorder?
pp. 269s-269s(1)
Authors: Dahl A.A.; Wiborg I.M.

Event-related potentials in obsessive-compulsive disorders: electrophysiological correlates of abnormal cognition
pp. 270s-270s(1)
Authors: Dietrich D.E.; Emrich H.M.; Becker H.; Munte T.F.

Effects of challenge with meta-chlorophenylpiperazine (mCPP) at behavior and cerebral blood flow in obsessive compulsive disorder
pp. 270s-270s(1)
Authors: K. L.H.P.; Westenberg H.G.M.; den Boer J.A.; de Bruin W.I.; van Rijk P.P.

Cerebral uptake of 99m-Tc-HMPAO is stable in obsessive compulsive disorder (OCD) during exposure in-vivo on split dose single photon emission tomography (SPET)
pp. 270s-270s(1)
Authors: Lucey J.V.; Burness C.; Costa D.C.; Busatto G.; Marks I.M.; Ell P.J.; Kerwin R.W.

The galway study of panic disorder IV: temporal stability of diagnosis by present state examination test retest
pp. 270s-271s(2)
Authors: O'Rourke D.; Fahy T.J.; Prescott P.

''Fear Fighter,'' behavioural self-help for agoraphobia on computer multimedia -- a new system
pp. 271s-271s(1)
Authors: Shaw S.C.; Marks I.M.

The benzodiazepine antagonist flumazenil is anxiolytic in high state anxiety and anxiogenic in low state anxiety in a study of 23 female animal phobics
pp. 271s-271s(1)
Authors: Trabert W.; Roth W.T.; Taylor C.B.

Decreased peripheral-type benzodiazepine receptor in posttraumatic stress disorder
pp. 271s-271s(1)
Authors: Weizman R.; Laor N.; Bidder M.; Fisher D.; Fonia O.; Muller U.; Reiss A.; Wolmer L.; Karp L.; Gavish M.

Psychiatric morbidity in the bone marrow transplantation setting
pp. 272s-272s(1)
Authors: Blanch J.; Prieto J.M.; Atala J.; Gasto C.; Cirera E.

The Cardiff chronic fatigue syndrome (CFS)
pp. 272s-272s(1)
Authors: Farmer A.; Jones I.; Smith A.; Borysiewicz L.; Llewellyn M.

Emotional adaptation of children in the life island after bone marrow transplantation
pp. 272s-272s(1)
Authors: Gunter M.; Karle M.; Werning A.; Klingebiel T.

Emotional distress and occupational burnout in nurses and physicians dealing with H.I.V. patients: a comparison with oncology and internal medicine services
pp. 272s-272s(1)
Authors: Lopez-Castillo J.J.; Gurpegui M.; Ayuso-Mateos J.L.; Luna J.D.

Affective disorders in the partners of cancer patients: prevalence, course & risk factors
pp. 272s-273s(2)
Authors: Haddad P.; Pitceathly C.; Jones B.; Maguire P.

A double-blind placebo controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome (CFS)
pp. 273s-273s(1)
Authors: Morriss R.; Wearden A.; Mullis R.; Strickland P.; Appleby L.; Campbell I.; Pearson D.

Prevalence of depression during hospitalization for bone marrow transplantation: effects of diagnostic criteria
pp. 273s-273s(1)
Authors: Prieto J.M.; Blanch J.; Atala J.; Gasto C.; Cirera E.

Psychosocial assessment of transplant patients. The Greek experience
pp. 273s-274s(2)
Authors: Syngelakis M.; Vidalis A.; Kaprinis G.

Health promotion in the drug subculture
pp. 274s-274s(1)
Authors: Fuchs W.J.; Grob P.J.

Validation of the alcohol use disorders identification test (audit) -- Romanian version for ICD-10 diagnoses
pp. 274s-274s(1)
Author: Jianu A.

Epidemiology of alcoholism in the European Russian North
pp. 274s-274s(1)
Authors: Kalinin A.; Sidorov P.

A comparative study on the motivation of drug addicts admitted to methadone maintenance treatment (UK, London SW -- Bulgaria, Sofia)
pp. 274s-275s(2)
Author: Kutsenok I.

An integrative relapse prevention program for alcoholics
pp. 275s-275s(1)
Authors: Lauer G.; Kunz A.; Schreiber S.; Stern G.; Sohns R.

Art-psychotherapy in drug-addiction
pp. 275s-275s(1)
Author: Marinow A.

Methadone versus intravenous opiate addiction: the evaluation of a substitution programme
pp. 275s-275s(1)
Authors: Sperner-Unterweger B.; Miller C.; Eisterer W.; Thaler J.; Raudaschl-Weskamp B.; Riemer Y.

Alcohol use and abuse among refugees
pp. 275s-276s(2)
Authors: Thaller V.; Breitenfeld D.; Buljan D.

A prospective study of dementia with lewy bodies -- clinical data
pp. 276s-276s(1)
Authors: Ballard C.G.; Lowery K.; Harrison R.; McKeith I.

A possible marker for Alzheimer's disease: in vivo detection with anticholinergic eye drops
pp. 276s-276s(1)
Authors: Chalhoub N.; Gilluley P.; Sacks B.

A longitudinal study on quantitative morphometric CT parameters in patients with probable Alzheimer's disease
pp. 276s-276s(1)
Authors: Hentschel F.; Zerfass R.; Besthorn C.; Sattel H.; Forstl H.

Neuroleptic medication worsens the cognitive decline of dementia
pp. 277s-277s(1)
Authors: McShane R.; Hope T.; Jacoby R.

Apolipoprotein E polymorphism, calcium and Alzheimer's disease
pp. 277s-277s(1)
Authors: Muller W.; Berlin K.; Marz W.; Ohm T.G.

Differential diagnosis of depression and dementia in geriatric patients by quantitative magnetic resonance imaging
pp. 277s-277s(1)
Authors: Pantel J.; Dech H.; Essig M.; Knopp M.V.; Schad L.R.; Friedlinger M.; Popp D.; Schroder J.

MRI computer assisted linear brain ratios, and neuropsychology of treatment resistant depression in the elderly
pp. 277s-278s(2)
Authors: Simpson S.; Baldwin B.; Jackson A.; Burns A.

What are the factors influencing prescribing of cognition enhancers
pp. 278s-278s(1)
Authors: Stoppe G.; Sandholzer H.; Saaedt J.; Winter S.; Kiefer J.; Ruther E.

Visual form perception in schizophrenia: further evidence for a disorder of semantic memory
pp. 278s-278s(1)
Authors: Gabrovska V.; Laws K.; McKenna P.J.

Long-term relapse prevention with clozapine in schizophrenia
pp. 278s-278s(1)
Authors: Klimke A.; Loffler S.; Klieser E.

Clozapine and the neuropsychology of schizophrenia
pp. 279s-279s(1)
Authors: Mortimer A.M.; Dye S.

CPT-linked schizophrenia vulnerability, psychosis proneness and frontal dysfunction in normal adolescents
pp. 279s-279s(1)
Authors: Obiols J.E.; Serrano F.; Barrantes N.; Garcia-Marimon M.; Gras E.; Bosch S.; Caparros B.; Carandell F.

Cognitive neuropsychology of delusional misidentification syndromes
pp. 279s-280s(2)
Authors: Oyebode F.; Edelstyn N.M.J.; Riddoch N.M.J.; Humphreys G.W.

Amisulpride in the treatment of acute exacerbations of subchronic or chronic schizophrenia: a dose range finding study
pp. 280s-280s(1)
Authors: Puech A.J.; Fleurot O.; Rein W.

Clozapine and risperidone in the treatment of therapy-resistant schizophrenia: a preliminary report on two ongoing clinical trials
pp. 280s-280s(1)
Authors: Konrad C.; Schormair C.; Eikelmann B.; Berger K.; Rottmann P.

Psychopathology and cognitive (executive) dysfunction in relation to duration of initially untreated psychosis in schizophrenia
pp. 280s-281s(2)
Authors: Scully P.J.; Coakley G.; Kinsella A.; Youssef H.A.; Waddington J.L.

Outcome of rehabilitation programme: is there a differential response?
pp. 281s-281s(1)
Author: Bhat M.

Service provision -- a different approach to Mother and Baby Services in New South Wales, Australia. The Wentworth Tresillian
pp. 281s-281s(1)
Authors: Bialas I.; Boyle G.

Service provision -- a different approach to community mental health team service organisation in New South Wales, Australia. The Wentworth area mental health service
pp. 281s-282s(2)
Authors: Bialas I.; Wheeler M.

Can lack of quality in acute psychiatric care be identified by analyzing routine data from a psychiatric information system?
pp. 282s-282s(1)
Authors: Loevdahl H.; Friis S.

Professionals views on patients' social functioning in the long-term treatment
pp. 282s-282s(1)
Author: Malyarov S.A.

Families and mental illness initiative
pp. 282s-282s(1)
Authors: Murphy M.; Antweiler U.

Continuing care of the long term mentally ill. A study of the role of general practitioners and the multi-disciplinary team
pp. 282s-283s(2)
Author: Scott J.

Public education for community care: a new approach
pp. 283s-283s(1)
Authors: Wolff G.; Leff J.

Prison based psychiatrists and the needs of mentally disordered remand prisoners
pp. 283s-283s(1)
Authors: Brown P.M.; Bhui K.S.; Hardie T.J.; Parrott J.M.; Watson J.P.

Deliberate self-harm in females in a special hospital: self-harmers and non-self harmers compared
pp. 283s-284s(2)
Authors: Low G.; Terry G.; Power M.; MacLeod A.; Duggan C.

Magnetic resonance tomography of the brain in 21 sex offenders
pp. 284s-284s(1)
Authors: Eher R.; Aigner M.; Wagner E.; Gutierrez K.

The insanity defence in Ireland: a study of guilty but insane patients 1850-1995
pp. 284s-284s(1)
Authors: Gibbons P.; Mulryan N.; O'Connor A.

Deprivation of liberty in psychiatric treatment
pp. 284s-284s(1)
Author: Kaltiala-Heino R.

Criterion-based audit of epilepsy in both community and hospital settings in seven districts
pp. 284s-285s(2)
Authors: Morris M.; James R.; Rowe D.; Brylewski J.; Abell S.

Psychopathological states of paraphilic behaviour
pp. 285s-285s(1)
Author: Tkachenko A.A.

Lower frequency of APOE E allele in an older down's syndrome population
pp. 285s-285s(1)
Authors: Tyrrell J.; Cosgrave M.; Lawlor B.; Gill M.

An investigation into extrapyramidal side effects induced by neuroleptics and their relationship to creatine phosphokinase
pp. 285s-285s(1)
Authors: Atkins M.; Camprubi M.; Evans J.; Ball S.G.; Riccio M.

Patterns of childhood social development in schizophrenia, bipolar disorder and normal controls
pp. 286s-286s(1)
Authors: Cannon M.; Jones P.B.; Gilvarry C.M.; Foerster A.; McKenzie K.; Rifkin L.; Murray R.M.

A two year follow up study of the first 50 patients to start clozapine in rampton hospital
pp. 286s-286s(1)
Authors: Dalal B.M.; Larkin E.P.; Taylor P.J.

Dermatoglyphic abnormalities in schizophrenia
pp. 286s-286s(1)
Authors: Fearon P.; Lane A.; Airey M.; Scannell J.; McGowan A.; Larkin C.; O'Callaghan E.

P300: A marker for genetic vulnerability to schizophrenia
pp. 286s-287s(2)
Authors: Frangou S.; Alarcon G.; Sharma T.; Sigmudsson T.; Binnie C.; Murray R.M.

Abnormal involuntary movements in schizophrenia; prevalence in treated and first episode samples
pp. 287s-287s(1)
Authors: Gervin M.; Lane A.; Browne S.; Kinsella A.; O'Callaghan E.; Larkin C.

Human dopamine D4 gene expression using the ribonuclease protection assay
pp. 287s-287s(1)
Authors: Stefanis N.; Bresnick J.; Kerwin R.; McAllister G.

Transcultural research on depression--study concept and preliminary results from a kenyan population
pp. 287s-288s(2)
Authors: Dech H.; Ndetei D.M.; Richter P.; Kathuku D.M.; Sandermann S.; Othieno C.; Mundt C.

Psychological autopsy in psychiatric patients who attempt deliberate self-harm (preliminary results)
pp. 288s-288s(1)
Authors: Gruffudd-Jones A.; Jenkins P.

Are women with severe blues at increased risk of postpartum depression?
pp. 288s-288s(1)
Authors: Henshaw C.; Foreman D.; O'Brien S.; Cox J.

Disturbances of perception in depressive disorders
pp. 288s-289s(2)
Author: Kallert T.W.

Psychological autopsy study of suicide in high risk occupational groups
pp. 289s-289s(1)
Authors: Malmberg A.K.; Hawton K.E.; Simkin S.; Fagg J.

Trends in suicide in Northern Ireland 1922-1992
pp. 289s-289s(1)
Author: McCrea P.H.

Prolonged depression: coping styles and therapy outcome
pp. 289s-289s(1)
Authors: Moukhine A.; Zorin V.

Suicide in Greece: regional distribution and relationship to socioeconomic development
pp. 289s-289s(1)
Authors: Zacharakis C.; Madianos M.; Stefanis C.

The Melbourne family grief study: perceptions of family functioning in bereavement
pp. 290s-290s(1)
Author: Bloch S.

Transcranial magnetic stimulation a new therapeutic approach to the treatment of depressive illness
pp. 290s-290s(1)
Authors: Conca A.; Koppi S.; Swoboda E.; Krecke N.; Konig P.

Electrophysiological correlates of impairment of imaginability in depressive patients
pp. 290s-290s(1)
Authors: Dietrich D.E.; Emrich H.M.; Schneider U.; Munte T.F.

Time to remission in major depression. Is there a link between 'no-treatment interval' and outcome?
pp. 290s-291s(2)
Authors: Gormley N.; O'Leary D.

-endorphin and immunodysfunction in depression and anxiety disorders
pp. 291s-291s(1)
Authors: Castilla-Cortazar I.; Subira M.L.; Gurpegui M.; Castilla A.

In vivo brain pet responses and neuroendocrine alterations following serotonin release in depressed patients versus healthy controls
pp. 291s-291s(1)
Authors: Malone K.M.; Anjilvel S.; Campbell C.; Shuhua L.; Mintun M.M.; Mann J.J.

Development of the comprehensive descriptive and severity scale of bereavement: the stardust bereavement scale
pp. 291s-292s(2)
Author: Mullaney J.A.

Melatonin secretion in seasonal affective disorder
pp. 292s-292s(1)
Authors: Partonen T.; Lonnqvist J.

A comparison of paroxetine and imipramine in six months continuation therapy post ECT
pp. 292s-292s(1)
Authors: Bech P.; Lauritzen L.; Odgaard K.; Clemmensen L.; Lund M.; Ohrstom J.; Black C.

Pharmacological evidence that depressive symptoms do not share a common serotonergic mechanism across diagnoses
pp. 292s-293s(2)
Authors: Cleare A.J.; Abel K.M.; O'Keane V.

Lithium and serotonin reuptake inhibitors; therapeutic or toxic?
pp. 293s-293s(1)
Authors: Hawley C.; Quick S.; Starr B.; McPhee S.; Sivakumaran T.

'Serotonergic autoreceptor blockade in the reduction of antidepressant latency: A controlled trial'
pp. 293s-293s(1)
Authors: Tome M.B.; Harte R.; Isaac M.T.

Prospective study of the effects of interrupting antidepressants
pp. 293s-293s(1)
Authors: Mourad I.; Lejoveux M.; Ades J.

Evaluation of strategies in therapy-resistant depression
pp. 293s-294s(2)
Authors: Lenz G.; Bailer U.; Serim M.

'Comparison of serotonin levels in depression treated by new and standard antidepressant regimes'
pp. 294s-294s(1)
Authors: Tome M.B.; Isaac M.T.

Superiority of lithium over verapamil in mania: a randomised controlled trial
pp. 294s-294s(1)
Authors: Walton S.A.; Berk M.; Brook S.

Psychogenic trauma and transient psychosis
pp. 294s-294s(1)
Author: Bower H.

Treating physicians with psychotherapy
pp. 294s-294s(1)
Author: Myers M.F.

Consulting to mental health organisations
pp. 294s-295s(2)
Authors: Obholzer A.; Stokes J.

Relevance-oriented video therapy (ROVT). A therapeutic platform based on human information processing
pp. 295s-295s(1)
Author: Sanford E.F.

What about the prescription of a psychotherapy 150 years after esquirol?
pp. 295s-296s(2)
Authors: Zins-Ritter M.; Sanchez-Cardenas M.

Psychoeducational training in schizophrenic patients
pp. 296s-296s(1)
Authors: Classen W.; Schwenkmezger P.; Heinrich M.; Schafer-Krajewski C.; Boesken S.

The attribution of intentionality, causality and disposition by deluded patients
pp. 296s-296s(1)
Authors: Done D.J.; Millard V.; Pattinson H.A.; Papanastasiou M.

? A new and familial variant of schizophrenia
pp. 296s-296s(1)
Authors: Doody G.A.; Muir W.J.; Johnstone E.C.; Owens D.G.C.

Auditory hallucinations in profoundly deaf schizophrenic patients: a phenomenological analysis
pp. 296s-297s(2)
Authors: Du Feu M.; McKenna P.J.

Psychoeducational intervention on the relatives' knowledge about schizophrenia: a twelve month follow up
pp. 297s-297s(1)
Authors: Economou M.; Madianos M.G.

The use of the expressed emotion index as a predictor of outcome in first admitted schizophrenic patients in a French speaking area of Switzerland
pp. 297s-297s(1)
Authors: Huguelet P.; Favre S.; Binyet S.; Gonzalez C.; Zabala I.

Late onset schizophrenia -- a valid entity? An empirical study on risk factors, psychopathology and course
pp. 297s-297s(1)
Authors: Riecher-Rossler A.; Hafner H.; Munk-Jorgensen P.

Violent behaviour in schizophrenics -- caused by schizophrenia itself or by premorbid behaviour disorder?
pp. 297s-298s(2)
Authors: Steinert T.; Voellner A.; Hermer K.

Acute ethanol withdrawal is associated with decreased striatal dopamine transporter levels?
pp. 298s-298s(1)
Authors: Ahonen A.; Laine T.P.J.; Niemela O.; Rasanen P.; Torniainen P.; Heikkila J.; Pyhtinen J.; Hillbom M.; Hiltunen J.

MDMA (ecstasy)-abuse in young adults -- is there a risk profile for severe psychiatric disorders?
pp. 298s-299s(2)
Author: Bilke O.

Compliance with psychopharmaca -- clinical prescription maintains how long?
pp. 299s-299s(1)
Authors: Klug G.; Rosmann D.; Thunhart A.; Ohner H.; Wiesinger S.; Haberl C.; Likar R.; Brodmann W.C.

The latest treatment possibility of korsakow syndrome with fluvoxamine and cognitiv training
pp. 299s-299s(1)
Authors: Kornyey E.; Nemes R.; Fornadi A.

Criteria for carbamazepine and clomethiazole treatment regimen of alcohol withdrawal
pp. 299s-299s(1)
Authors: Lemke M.R.; Bauer W.; Badent U.; Hartmann W.

Subjective and behavioral responses and event related potentials following cocaine administration in subjects with and without a family history of alcoholism
pp. 299s-299s(1)
Authors: Martinez-Raga J.; Lukas S.E.; Sholar M.B.; Eros-Sarnyai M.; Wines J.

Which PCP-like NMDA-receptor antagonists are available for clinical use?
pp. 300s-300s(1)
Authors: Retz W.; Riederer P.; Kornhuber J.

Serotonin syndrome: 4 case reports and a review
pp. 300s-300s(1)
Authors: Verhoeven W.M.A.; Tuinier S.; Noten J.B.G.M.; van Gogh V.

Relationship between personality disorders and eating disorders
pp. 300s-300s(1)
Authors: Besharat A.; Dare C.; Eisler I.

Obsessional symptoms in patients with eating disorders and their relationship to outcome
pp. 301s-301s(1)
Authors: Cryan E.; Harrington D.; Darby M.; Walsh N.

Prediction of course and mortality of eating disorders in Denmark, 1970-93. A national case register study
pp. 301s-301s(1)
Author: Emborg C.

Depression, family environment and adolescent suicidal behaviour
pp. 301s-301s(1)
Author: Hollis C.P.

Abstract(s)
pp. 301s-302s(2)
Authors: Laurent A.; Foussard N.; Boucharlat J.; Debru J.L.; Bost M.

Forgiveness: an comparison between prosocial and aggressive children
pp. 302s-302s(1)
Authors: Pejovic M.M.; Lakic A.

Abstract(s)
pp. 302s-302s(1)
Authors: Rouer-Saporta S.A.; Divac S.M.; Samuel-Lajeunesse B.

The long-term course of childhood obsessive-compulsive disorder
pp. 302s-302s(1)
Author: Thomsen P.H.

Epidemiology of bipolar disorder: new data
pp. 302s-303s(2)
Author: Angst J.

Different enlargement of internal and external CSF spaces in endogenous and so-called neurotic depression. A planimetric CT-scan study
pp. 303s-303s(1)
Authors: Baumann B.; Bornschlegl C.; Krell D.; Bogerts B.

Discriminating patterns of regional cerebral blood flow (rCBF) in three sub-types of depression. A longitudinal spect study
pp. 303s-303s(1)
Authors: Girala N.; Zapata R.; Arbizu J.

Anhedonia, alexithymia and locus of control in major depressive disorders
pp. 303s-303s(1)
Authors: Loas G.; Dhee-Perot P.; Chaperot C.; Fremaux D.; Gayant C.; Boyer P.

Resistant depressions - concept and therapy approach
pp. 304s-304s(1)
Authors: Milovanovic S.; Zvkovic D.; Stankovic Z.; Milovanovic D.

Biorhythms, affective disorders and the vulnerability/stress theory. A theoretical model and direction of research
pp. 304s-304s(1)
Author: Nicoara O.

Neuroendocrine abnormalities in bipolar mania and major depressive illness
pp. 304s-304s(1)
Authors: Thakore J.H.; Dinan T.G.

Endogenous vs neurotic depression: is the ICD-10 concept of recurrent affective disorder tenable?
pp. 304s-304s(1)
Authors: Vetter P.; Pritzbuer J.V.; Kropp P.

Obstetric complications and psychopathology in schizophrenic patients
pp. 305s-305s(1)
Authors: Bersani G.; Venturi P.; Taddei I.

Alcohol and drug comorbidity in a first onset psychosis cohort
pp. 305s-305s(1)
Authors: Cantwell R.; Brewin J.; Dalkin T.; Fox R.; Glazebrook C.; Medley I.; Harrison G.L.

Cannabis and schizophrenia -- a follow-up
pp. 305s-305s(1)
Author: Caspari D.

Schizophrenia and urban life
pp. 305s-305s(1)
Author: Freeman H.

Does substance abuse precipitate schizophrenia?
pp. 305s-306s(2)
Authors: Hambrecht M.; Hafner H.

Alcohol use and abuse in patients suffering from schizophrenic disorders in corfu island
pp. 306s-306s(1)
Authors: Simatis P.; Alexandropulos K.; Tzortzopulu M.; Kavadi V.

Schizophrenic psychoses and mutations of the ciliary neurotrophic factor (CNTF) and neurotrophin 3 (NT3) genes: evidence for the maldevelopmental theory
pp. 306s-306s(1)
Authors: Thome J.; Baumer A.; Harsanyi A.; Foley P.; Kornhuber J.; Rosler M.; Riederer P.

Increased morbid risk of schizophrenia in relatives of patients with severe bipolar disorder
pp. 306s-307s(2)
Authors: Valles V.; Guillamat R.; Fananas L.; Gutierrez B.; Campillo M.; van Os J.

Dissociative, somatoform and borderline disorders -- combination and differentiation in adolescents
pp. 307s-307s(1)
Authors: Bilke O.; Eggers C.

An attachment-based approach to the management and psychotherapy of borderline personality disorder
pp. 307s-307s(1)
Author: Holmes J.

Echo of the disaster at the chernobyl's nuclear power station. Psychotherapy of the victims
pp. 307s-307s(1)
Author: Kirilenko Y.V.

Masochistic clinging object relationship/attachment in adults a (hitherto not described) consequence of chronic physical child abuse
pp. 308s-308s(1)
Author: Samitca D.C.

Childhood traumas: a link between agoraphobia and personality disturbance
pp. 308s-308s(1)
Authors: Starcevic V.; Bogojevic G.; Kelin K.

Pharmacological implications of dimensional perspectives in borderline personality disorders
pp. 308s-308s(1)
Authors: Tuinier S.; Marijnissen G.M.; van den Berg Y.W.M.M.; Verhoeven W.M.A.; Pepplinkhuizen L.

Forensic group analysis: the treatment in psychotherapeutic groups of victims and perpetrators of incest
pp. 308s-308s(1)
Author: Welldon E.V.

Risk and protective factors for mental health in adolescence
pp. 309s-309s(1)
Authors: Aalto-Setala T.; Tuulio-Henriksson A.; Pitkanen T.; Poikolainen K.; Lonnqvist J.

Age pathomorphosis of alcoholism clinical symptoms, currents and outcomes
pp. 309s-309s(1)
Authors: Abramichev A.; Antropov A.; Antropov Y.; Volkova S.; Ponomarenko I.; Sgibova V.; Yavorski V.; Yaldygina A.

Clonidine abuse - risk in the psychiatric population?
pp. 309s-309s(1)
Authors: Agelink M.W.; Dammers S.; Schar V.; Leonhardt M.; Zeit T.

Prospective study of maternity blues and postpartum depression
pp. 309s-310s(2)
Authors: Aguado J.A.; Moreno P.L.; Del Palacio R.

ADH/ALDH2 and DRD2 gene PCR polymorphism in alcohol polynesian users
pp. 310s-310s(1)
Authors: Amadeo S.; Carr L.; Nicolas L.; Fourcade-Amadeo M.L.; Tetaria C.; Xuxiang Z.; Ritchie T.; Perez D.; Brugiroux M.F.; Sinjoux I.; Ting K.L.; Martin P.; Noble E.; Mallet J.

Depressive disorders among outpatients with glaucoma
pp. 310s-310s(1)
Authors: Ames D.; Crawford A.; Rait J.; Healey D.

Regulation of the brain catecholamine system functions as a basis for the pharmacological treatment of alcoholism
pp. 310s-310s(1)
Author: Anokhina I.P.

Separation anxiety disorder: a risk factor for drug addiction?
pp. 311s-311s(1)
Authors: Bailly D.; Bailly-Lambin I.; Garzon G.

Psychopathology of patients with fibromyalgia
pp. 311s-311s(1)
Authors: Batra A.; Kotter I.; Bartels M.

Antibody reactivity against H3-histones in fibromyalgia
pp. 311s-311s(1)
Authors: Batra A.; Haegele A.; Bartels M.; Schott K.

Borna Disease Virus - a possible causal factor in psychiatric disorders
pp. 311s-311s(1)
Authors: Bechter K.; Herzog S.; Schuttler R.

Multiple sclerosis (MS) manifesting with psychiatric disturbances
pp. 311s-312s(2)
Author: Becker H.

A comparison of psychiatric and diabetic patients given access to their own medical records
pp. 312s-312s(1)
Authors: Jha A.; Bernadt M.; Brown K.; Sawicka E.

Prevalence and economic inpact of substance use in clients utilising the rehabilitation services of the wentworth area health service new south Wales, Australia
pp. 312s-312s(1)
Authors: Harris A.; Bialas I.